I. Glenn Cohen | |
---|---|
![]() I. Glenn Cohen at the Edmond J. Safra Center for Ethics in 2022. | |
Born | 1978 (age 45–46) Montreal, Quebec, Canada |
Education | University of Toronto (BA) Harvard University (JD) |
Occupation(s) | Professor Director, Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics Associate Member, Broad Institute |
Employer | Harvard Law School |
Known for | Bioethics & law; health law; medical tourism, reproductive technology |
Website | I. Glenn Cohen. Harvard Law School Faculty Page |
I. Glenn Cohen (born 1978 in Montreal, Quebec, Canada) is a Professor of Law at Harvard Law School. He is also the director of Harvard Law School's Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics.[1]
Cohen has written a number of articles, appearing in journals such as the New England Journal of Medicine; JAMA; Cell; Nature; the Harvard, Stanford, Southern California, Minnesota, Iowa, and Hastings Law Reviews; the Harvard Journal of Law and Negotiation; the Harvard Journal of Law and Technology; the Food and Drug Law Journal; the Journal of Law, Medicine and Ethics; and the Hastings Center Reports. He has given interviews and been cited by the New York Times,[2] Politico,[3] CNN,[4] ABC News,[5] MSNBC,[6] The Boston Globe, Mother Jones,[7] NPR,[8] PBS,[9] and AOL News.[10]
After graduating from Bialik High School in 1996, Cohen attended the University of Toronto where he received an Hon. B.A. in Bioethics (Philosophy) and Psychology in 2000. He served as a Primary Editor on the Harvard Law Review and published two student notes. He received his J.D., magna cum laude, in 2003.[1]
He served as a law clerk for Judge Michael Boudin of the United States Court of Appeals for the First Circuit from 2003–2004 and then worked on the Appellate Staff in the Civil Division of the United States Department of Justice from 2004-2006.
In 2006, Cohen returned to Harvard as an Academic Fellow & Lecturer On Law at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics. Upon completing his fellowship, in 2008, Cohen became a tenure-track professor at Harvard Law School and was tenured as a full professor in 2013.[11] Cohen's work lies at the intersection of law and bioethics. His current projects focus on big data, health information technology, technology in medicine, telemedicine, rationing in law and medicine, FDA law, and medical tourism.
Cohen was selected as a Radcliffe Institute Fellow for the 2012-2013 year[12] and is a fellow at the Hastings Center,[1] one of the leading bioethics think tanks in the United States.
He is also one of the lead co-investigators in the NFL Football Players Health Study at Harvard.[13] He spearheads the Ethics and Law initiative at Harvard Catalyst, an NIH-supported clinical and translation science initiative.[14]
He is a board member of the Association of American Law Schools, Law, Medicine, and Health Care Section Executive Committee and served as a board member of the Institutional Review Board for Fenway Health from 2007-2010.[15] He became co-editor-in-chief of The Journal of Law and the Biosciences in 2013 and has served as a peer reviewer in the New England Journal of Medicine and The Lancet.
Cohen authored the "Lander Brief"[16] that was discussed extensively at oral argument[17] in Association for Molecular Pathology v. Myriad Genetics, Inc., which held that naturally occurring DNA sequences could not be patented.